Drug Development and Industrial Pharmacy

Papers
(The H4-Index of Drug Development and Industrial Pharmacy is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
In vivo behavior of technetium-99m labeled ibuprofen in infection and inflamation animal models31
Polymeric oral fast dissolving films of metformin: fabrication, optimization, in vitro, and in vivo evalua31
A QbD approach for optimizing the lyophilization parameters of cyclophosphamide monohydrate30
Construction of albumin-based nanoparticles utilizing paclitaxel-fatty acid prodrug that mimicking the natural fatty-acid binding process in vivo to syne28
Development and characterization of 3D printed ethylene vinyl acetate (EVA) as drug delivery device for the treatment of overactive bladder23
Formulation, biopharmaceutical evaluation and in-vitro screening of polyherbal phytosomes for breast cancer therapy21
Radioprotective effect of nanoniosome loaded by Mentha Pulegium essential oil on human peripheral blood mononuclear cells exposed to ionizing radiation20
Establishing virtual bioequivalence and bio-related dissolution specifications for naproxen using physiologically based pharmacokinetic modeling and in vitro biorelevant20
Studies on ameliorative potentials of quercetin nanoparticles against imidacloprid induced subacute genotoxicity and histopathological alteration in Swiss albino mice19
Intranasal delivery of metal/metal oxide nanoparticles for the management of CNS-related diseases: theranostic and toxicity issues19
Ginkgolic acid as a fusion inhibitor: targeting RBD-ACE2 interaction with in silico, in vitro evidence of allosteric modulation and potent virucidal effect19
Polymyxin B and silver nanoparticles: a nanotechnology-driven approach to overcome antibiotic resistance17
Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment: in-vitro and in-vivo evaluation17
Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model16
Use of nanoemulsion for co-delivery of silibinin and cabazitaxel for prostate cancer treatment16
Improving cellular uptake and synergetic anti-tumor effects of magnolol and Brucea javanica oil through self-microemulsion15
0.14390897750854